Trade Cerus Corp - CERS CFD
What is Cerus Corp (CERS)?
Cerus Corporation is a biotechnology company specializing in the development and commercialization of technologies aimed at improving the safety of blood transfusions. The company focuses on pathogen reduction technology designed to inactivate a broad range of viruses, bacteria, and parasites in donated blood components. Cerus's primary product utilizes a proprietary process involving a photosensitive compound combined with ultraviolet light to treat platelets and plasma, thereby reducing the risk of transfusion-transmitted infections. The company operates within the healthcare and life sciences sector, serving blood centers, hospitals, and transfusion services globally. Cerus collaborates with regulatory agencies to ensure compliance with safety standards and to facilitate the adoption of its technologies. Its research and development efforts continue to explore applications of its pathogen reduction technology to other blood components and medical fields. Cerus Corporation's activities contribute to enhancing transfusion safety and supporting public health initiatives related to blood product management.
Cerus Corp Stock Price Today: Live Overview
The price today is shaped by ongoing market movements as Cerus Corp trades at $1.87. The day's range spans from $1.78 to $1.86 with a percentage change of -0.5376%.
FAQ: Cerus Corp (CERS)
What is the current price of CERS stock?
The stock is currently priced at $1.87.
Does CERS pay dividends?
Cerus Corp does not pay dividends.
Does CERS have a formal corporate presence or regional headquarters in the UAE?
Cerus Corp has no official office or subsidiary in the UAE and operates via local partners.
What is CERS best known for?
Cerus Corp is most famous for its INTERCEPT Blood System used in blood safety technology.
What assets are typically shown together with CERS?
Commonly shown alongside CERS: AJ Bell Plc, Mission Produce Inc, Advance Auto
Latest shares articles



